Inventiva (IVA) Granted FDA's Fast Track Designation of lanifibranorin NASH Encompasses the Treatment of NASH with Compensated Cirrhosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Inventiva (IVA) Granted FDA's Fast Track Designation of lanifibranorin NASH Encompasses the Treatment of NASH with Compensated Cirrhosis
VALUERICH, Inc. (NASDAQ: IVA) Delayed: 3.85 +0.05 (1.32%)
Previous Close $3.80    52 Week High $0.40 
Open $3.87    52 Week Low $0.11 
Day High $3.97    P/E N/A 
Day Low $3.80    EPS $-0.03 
Volume 1,009,393